Cargando…

Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

Corticotropin-releasing factor (CRF) has been identified in intestinal mucosal eosinophils and associated with psychological stress and gut dysfunction. Irritable bowel syndrome (IBS) is commonly characterized by altered intestinal motility, immune activation, and increased gut barrier permeability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvo-Romero, Eloísa, Martínez, Cristina, Lobo, Beatriz, Rodiño-Janeiro, Bruno K., Pigrau, Marc, Sánchez-Chardi, Alejandro D., González-Castro, Ana M., Fortea, Marina, Pardo-Camacho, Cristina, Nieto, Adoración, Expósito, Elba, Guagnozzi, Danila, Rodríguez-Urrutia, Amanda, de Torres, Inés, Farré, Ricard, Azpiroz, Fernando, Alonso-Cotoner, Carmen, Santos, Javier, Vicario, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692489/ https://www.ncbi.nlm.nih.gov/pubmed/33244004 http://dx.doi.org/10.1038/s41598-020-77176-x

Ejemplares similares

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations
por: Pardo-Camacho, Cristina, et al.
Publicado: (2022)

Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction
por: Rodiño-Janeiro, Bruno K., et al.
Publicado: (2018)

Role of Corticotropin-releasing Factor in Gastrointestinal Permeability
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2015)

Acute Stress Regulates Sex-Related Molecular Responses in the Human Jejunal Mucosa: Implications for Irritable Bowel Syndrome
por: Rodiño-Janeiro, Bruno K., et al.
Publicado: (2023)

Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction
por: Salvo-Romero, Eloísa, et al.
Publicado: (2022)

A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies
por: Rodiño-Janeiro, Bruno K., et al.
Publicado: (2018)

miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea
por: Martínez, Cristina, et al.
Publicado: (2017)

Present and Future Therapeutic Approaches to Barrier Dysfunction
por: Fortea, Marina, et al.
Publicado: (2021)

Towards a new paradigm of microscopic colitis: Incomplete and variant forms
por: Guagnozzi, Danila, et al.
Publicado: (2016)

The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults
por: Alonso-Cotoner, Carmen, et al.
Publicado: (2021)

The Intestinal Gas Questionnaire (IGQ): Psychometric validation of a new instrument for measuring gas‐related symptoms and their impact on daily life among general population and irritable bowel syndrome
por: Duracinsky, Martin, et al.
Publicado: (2021)

Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastructural Evaluation
por: Vanheel, Hanne, et al.
Publicado: (2018)

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2012)

CORTICOTROPINS (ACTH) : X. BIOLOGICAL INVESTIGATIONS ONα-CORTICOTROPIN
por: Li, Choh Hao, et al.
Publicado: (1957)

Natalizumab in the treatment of Crohn’s disease
por: Guagnozzi, Danila, et al.
Publicado: (2008)

Conditioning by a Previous Experience Impairs the Rewarding Value of a Comfort Meal
por: Nieto, Adoracion, et al.
Publicado: (2023)

Corticotropin-Releasing Hormone Receptor 1 Gene Variants in Irritable Bowel Syndrome
por: Sato, Naoko, et al.
Publicado: (2012)

Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome
por: Komuro, Hazuki, et al.
Publicado: (2016)

Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome
por: Chatoo, Mahanand, et al.
Publicado: (2018)

Intestinal Barrier Function in Chronic Kidney Disease
por: Meijers, Björn, et al.
Publicado: (2018)

Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis
por: Albert-Bayo, Mercé, et al.
Publicado: (2019)

Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome
por: Kano, Michiko, et al.
Publicado: (2017)

Corticotropin and Cortisone in Diseases of the Nervous System
por: Merritt, H. Houston
Publicado: (1952)

Is there any place to corticotropin test in sepsis?
por: Abdellatif, S, et al.
Publicado: (2004)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

Associations between Single-Nucleotide Polymorphisms in Corticotropin-Releasing Hormone-Related Genes and Irritable Bowel Syndrome
por: Sasaki, Ayaka, et al.
Publicado: (2016)

Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants
por: Alemany, Silvia, et al.
Publicado: (2023)

Medical Uses of Cortisone, Including Hydrocortisone and Corticotropin
por: Bondy, Philip K.
Publicado: (1955)

Regulation of gonadotropins by corticotropin-releasing factor and urocortin
por: Kageyama, Kazunori
Publicado: (2013)

Central corticotropin releasing factor and social stress
por: Backström, Tobias, et al.
Publicado: (2013)

Endocrinology and the brain: corticotropin-releasing hormone signaling
por: Inda, Carolina, et al.
Publicado: (2017)

Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities
por: Caruso, Alessandra, et al.
Publicado: (2022)

Cellular and Molecular Basis of Intestinal Barrier Dysfunction in the Irritable Bowel Syndrome
por: Martínez, Cristina, et al.
Publicado: (2012)

Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia
por: Seretis, C., et al.
Publicado: (2011)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome
por: BOUSABA, J., et al.
Publicado: (2023)

Organization of the corticotropin‐releasing hormone and corticotropin‐releasing hormone‐binding protein systems in the central nervous system of the sea lamprey Petromyzon marinus
por: Sobrido‐Cameán, Daniel, et al.
Publicado: (2022)

Blastocystis sp. Carriage and Irritable Bowel Syndrome: Is the Association Already Established?
por: Salvador, Fernando, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pcc7t3to60mddvl3sb4b66k8le